5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.40▲ | 2.40▲ | 2.40▲ | 2.48▼ | 2.51▼ |
MA10 | 2.40▲ | 2.40▲ | 2.40▲ | 2.54▼ | 2.04▲ |
MA20 | 2.39▲ | 2.41▼ | 2.41▼ | 2.53▼ | 2.49▼ |
MA50 | 2.40▲ | 2.46▼ | 2.54▼ | 1.89▲ | 4.38▼ |
MA100 | 2.41▼ | 2.55▼ | 2.60▼ | 2.64▼ | 4.02▼ |
MA200 | 2.41▼ | 2.59▼ | 2.22▲ | 3.84▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.005▲ | 0.007▲ | -0.052▼ | 0.153▲ |
RSI | 55.134▲ | 46.815▼ | 42.582▼ | 53.580▲ | 43.578▼ |
STOCH | 73.492 | 32.812 | 50.013 | 18.745▼ | 69.839 |
WILL %R | -25.000 | -55.000 | -34.375 | -82.031▼ | -43.213 |
CCI | 104.463▲ | 42.667 | 19.660 | -142.897▼ | 45.017 |
▲ GAP | $HUMA Open Gap Up %2 | Set Alert |
Wednesday, June 11, 2025 05:00 PM
DURHAM, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...
|
Wednesday, June 11, 2025 06:05 AM
Humacyte's Symvess offers a significant clinical advance in vascular trauma, with strong efficacy and cost benefits over synthetic grafts and autologous vein grafts. The company targets a $200M-$480M ...
|
Friday, May 30, 2025 06:29 AM
Let's take a look at what these Wall Street heavyweights have to say about Humacyte, Inc. (HUMA) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 2.44 | 2.46 | 2.37 | 2.405 | 1,042,962 |
13/06/25 | 2.30 | 2.46 | 2.29 | 2.37 | 2,722,400 |
12/06/25 | 2.50 | 2.5115 | 2.39 | 2.41 | 3,191,574 |
11/06/25 | 2.71 | 2.71 | 2.52 | 2.54 | 3,181,050 |
10/06/25 | 2.58 | 2.785 | 2.57 | 2.66 | 4,588,765 |
09/06/25 | 2.62 | 2.69 | 2.5181 | 2.56 | 4,859,540 |
06/06/25 | 2.66 | 2.93 | 2.58 | 2.59 | 6,643,516 |
05/06/25 | 2.64 | 2.735 | 2.57 | 2.62 | 4,155,842 |
04/06/25 | 2.63 | 2.87 | 2.60 | 2.63 | 4,896,985 |
03/06/25 | 2.62 | 2.76 | 2.49 | 2.61 | 4,111,892 |
|
|
||||
|
|
||||
|
|